{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-096510","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-08-14T12:36:29+00:00","discovered_at":"2026-08-14T12:40:00.428588+00:00","generated_at":"2026-08-14T12:40:06.576068+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Outlook Therapeutics raises ~$55M in public offering of common stock and warrants","bullets":["55,555,556 shares and warrants sold at $0.99 combined; gross proceeds ~$55M.","Warrants exercisable at $1.10/share, expire in 5 years; underwriters' option for 8.33M additional warrants exercised.","GMS Ventures (largest stockholder) bought 2,525,252 shares; CEO Robert Jahr and CFO Lawrence Kenyon bought 151,515 and 101,010 shares respectively.","Offering expected to close Aug 14, 2026; Piper Sandler and BTIG are underwriters."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-096510","json":"https://secwatch.observer/filing/0001104659-26-096510.json","markdown":"https://secwatch.observer/filing/0001104659-26-096510.md","text":"https://secwatch.observer/filing/0001104659-26-096510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926096510/0001104659-26-096510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926096510/tm2622399d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T12:40:06.576068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}